Skip to main content

Monoclonal Antibodies in Pancreatic Cancer: New Developments

  • Conference paper
Diagnostic Procedures in Pancreatic Disease
  • 70 Accesses

Abstract

The introduction of hybridoma technology [3] has opened a new era in immunological approaches to gastrointestinal malignancies. By means of monoclonal antibodies (MAbs), which represent immunoreagents of defined specificity and affinity, new tumor-associated antigens of the gastrointestinal (GI) tract have been identified and characterized. Moreover, monoclonal antibodies to GI tract cancer associated antigens have been used in diagnostic and as yet preliminary therapeutic clinical applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dippold WG, Lloyd KO, Li LTC, Ikeda HB, Oettgen HF, Old LJ (1980) Cell surface antigens of human malignant melanoma definition of six antigen systems with mouse monoclonal antibodies. Proc Natl Acad Sci USA 77: 6114–6118

    Article  PubMed  CAS  Google Scholar 

  2. Klapdor R, Lehmann U, Bahlo M, Greten H, v Ackeren H, Dallek M, Schreiber HW (1983) CA 19-9 in der Diagnostik und Differential diagnostik des exkretorischen Pankreaskarzinoms. Tumor Diagn Ther 4: 197–201

    Google Scholar 

  3. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497

    Article  PubMed  Google Scholar 

  4. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P (1979) Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 5: 957–972

    Article  PubMed  CAS  Google Scholar 

  5. Magnani JL, Brockhaus M, Smith DF, Ginsburg V, Blaszezyk M, Mitchell KF, Steplewski Z, Koprowski H (1981) A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212: 55–56

    Article  PubMed  CAS  Google Scholar 

  6. Magnani JL, Steplewski Z, Koprowski H, Ginsburg V (1983) Identification of the gastrointestinal and pancreatic cancer associated antigen detected by monoclonal antibody CA 19-9 in sera of patients as a mucin. Cancer Res 43: 5489–5492

    PubMed  CAS  Google Scholar 

  7. Mazauric T, Mitchell K F, Letchworth GJ, Koprowski H, Steplewski Z (1982) Monoclonal antibody defined human lung cell surface protein antigens. Cancer Res 42: 150–154

    PubMed  CAS  Google Scholar 

  8. Saxton RE, Mann BD, Ine RF, Morton DL, Burk M (1982) Monoclonal antibodies to human melanoma identification of two unique proteins on the tumor cell membrane. Proc Am Assoc Cancer Res 23: 362

    Google Scholar 

  9. Schmiegel WH, Kalthoff H, Kreiker C (1984) CA 19-9 bearing mucins-physiological pancreatic secretion products with specific endocrine-paracrine release in pancreatic cancer. Dig Dis Sci 29 /10: 967

    Google Scholar 

  10. Schmiegel WH, Kalthoff H, Arndt R, Gieseking J, Greten H, Klöppel G, Kreiker C, Ladak Lampe V, Ulrich S (1985) Monoclonal antibody-defined human pancreatic cancer-associated antigens. Cancer Res 45: 1402–1407

    PubMed  CAS  Google Scholar 

  11. Schmiegel WH, Kreiker C, Eberl W, Arndt R, Classen M, Greten H, Jessen K, Kalthoff H, Soehendra N, Thiele HG (1985) Monoclonal antibody defines CA 19-9 in pancreatic juices and sera. Gut 26: 456–460

    Article  PubMed  CAS  Google Scholar 

  12. Staab HJ, Hornung A, Anderer FA, Kieninger G (1984) Klinische Bedeutung des zirkulierenden tumorassoziierten Antigens CA 19-9 bei Karzinomen des Verdauungstrakts. Dtsch Med Wochenschr 109: 1141–1147

    Article  PubMed  CAS  Google Scholar 

  13. Ueda R, Ogata S, Morrisey DM, Finstad CC, Szkudiarek J, Whitmore WF, Oettgen HF, Lloyd KO, Old LJ (1981) Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies identification of tissue specific glycoproteins. Proc Natl Acad Sci USA 76: 5122–5126

    Article  Google Scholar 

  14. Villano BC, Brennan S, Brock P, Bucher C, Lun V, McClure M, Rake B, Space S, Westrick B, Schoemaker H, Zurawski V (1983) Radioimmunometric assay for a monoclonal antibody-defined tumor marker CA 19-9. Clin Chem 29 /3: 549–552

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schmiegel, WH. (1986). Monoclonal Antibodies in Pancreatic Cancer: New Developments. In: Malfertheiner, P., Ditschuneit, H. (eds) Diagnostic Procedures in Pancreatic Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71128-2_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71128-2_46

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71130-5

  • Online ISBN: 978-3-642-71128-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics